11:19 AM EDT, 10/23/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.70% to 1,389.07 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion Biotech ( EVAX ) , which advanced 39% and 3.1%, respectively. They were followed by telecommunications company VEON (VEON) and semiconductor company Sequans Communications ( SQNS ) , which rose 2.3% and 1.7%, respectively.

The decliners from continental Europe were led by consumer goods giant Unilever ( UL ) and accommodations booking company trivago (TRVG), which dropped 2.7% and 2.3%, respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and petroleum refiner Equinor ( EQNR ) , which lost 2.1% and 1.8%, respectively.

From the UK and Ireland, the gainers were led by communications company WPP (WPP) and biotech firm Trinity Biotech (TRIB), which rose 5% and 2.6%, respectively. They were followed by biopharmaceutical company Nucana ( NCNA ) and educational publisher Pearson (PSO), which were up 1.7% and 1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Bicycle Therpeutics, which lost 6.9% and 4.8%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Akari Therapeutics Plc ( AKTX ) , which fell 4.3% and 3%, respectively.